 | • レポートコード：MRC2-11QY01781 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインターロイキン阻害剤のグローバル市場について調査・分析したレポートです。種類別（インターロイキン1、インターロイキン2、インターロイキン3、インターロイキン4、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インターロイキン阻害剤の競争状況、市場シェア ・世界のインターロイキン阻害剤市場：種類別市場規模 2015年-2020年（インターロイキン1、インターロイキン2、インターロイキン3、インターロイキン4、その他） ・世界のインターロイキン阻害剤市場：種類別市場規模予測 2021年-2026年（インターロイキン1、インターロイキン2、インターロイキン3、インターロイキン4、その他） ・世界のインターロイキン阻害剤市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のインターロイキン阻害剤市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のインターロイキン阻害剤市場分析：米国、カナダ ・ヨーロッパのインターロイキン阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインターロイキン阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインターロイキン阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインターロイキン阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、GlaxoSmithKline、Novartis、Johnson & Johnson、Roche、Eli Lilly、AstraZeneca、Teva Pharmaceutical、Regeneron Pharmaceuticals、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Interleukin (IL) are group of cytokines that are synthesized by lymphocytes, monocytes, macrophages, and other cells. They regulate cell growth, cell differentiation, and cell motility. Fifteen different types of interleukin are present in body. Interleukin inhibitors are immunosuppressive agents that inhibit the action of interleukins. Interleukin inhibitors are used in various conditions including asthma, ankylosing spondylitis, eczema, gout, arthritis (psoriatic and rheumatoid), psoriasis, and systematic sclerosis.
North America is expected to hold a prominent share of the global market, due to rise in the patient pool suffering from psoriasis, arthritis, asthma, and other chronic inflammatory diseases. The presence of well-established drugs makers in North America is further expected to boost the market in the region.
Market Analysis and Insights: Global Interleukin Inhibitors Market
The global Interleukin Inhibitors market size is projected to reach US$ 19020 million by 2026, from US$ 16540 million in 2020, at a CAGR of 13.9%% during 2021-2026.
Global Interleukin Inhibitors Scope and Market Size
Interleukin Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Interleukin Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Interleukin Inhibitors market is segmented into
Interleukin 1
Interleukin 2
Interleukin 3
Interleukin 4
Others
Segment by Application, the Interleukin Inhibitors market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Interleukin Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Interleukin Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Interleukin Inhibitors Market Share Analysis
Interleukin Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interleukin Inhibitors business, the date to enter into the Interleukin Inhibitors market, Interleukin Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Sanofi
GlaxoSmithKline
Novartis
Johnson & Johnson
Roche
Eli Lilly
AstraZeneca
Teva Pharmaceutical
Regeneron Pharmaceuticals
Bausch Health
1 Study Coverage
1.1 Interleukin Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Interleukin Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Interleukin Inhibitors Market Size Growth Rate by Type
1.4.2 Interleukin 1
1.4.3 Interleukin 2
1.4.4 Interleukin 3
1.4.5 Interleukin 4
1.4.6 Others
1.5 Market by Application
1.5.1 Global Interleukin Inhibitors Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Interleukin Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Interleukin Inhibitors Revenue 2015-2026
2.1.2 Global Interleukin Inhibitors Sales 2015-2026
2.2 Global Interleukin Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Interleukin Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Interleukin Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Interleukin Inhibitors Competitor Landscape by Players
3.1 Interleukin Inhibitors Sales by Manufacturers
3.1.1 Interleukin Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Interleukin Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Interleukin Inhibitors Revenue by Manufacturers
3.2.1 Interleukin Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Interleukin Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Interleukin Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Interleukin Inhibitors Revenue in 2019
3.2.5 Global Interleukin Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Interleukin Inhibitors Price by Manufacturers
3.4 Interleukin Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Interleukin Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interleukin Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Interleukin Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Interleukin Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Interleukin Inhibitors Sales by Type (2015-2020)
4.1.2 Global Interleukin Inhibitors Revenue by Type (2015-2020)
4.1.3 Interleukin Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Interleukin Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Interleukin Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Interleukin Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Interleukin Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Interleukin Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Interleukin Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Interleukin Inhibitors Sales by Application (2015-2020)
5.1.2 Global Interleukin Inhibitors Revenue by Application (2015-2020)
5.1.3 Interleukin Inhibitors Price by Application (2015-2020)
5.2 Interleukin Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Interleukin Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Interleukin Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Interleukin Inhibitors Price Forecast by Application (2021-2026)
6 North America
6.1 North America Interleukin Inhibitors by Country
6.1.1 North America Interleukin Inhibitors Sales by Country
6.1.2 North America Interleukin Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Interleukin Inhibitors Market Facts & Figures by Type
6.3 North America Interleukin Inhibitors Market Facts & Figures by Application
7 Europe
7.1 Europe Interleukin Inhibitors by Country
7.1.1 Europe Interleukin Inhibitors Sales by Country
7.1.2 Europe Interleukin Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Interleukin Inhibitors Market Facts & Figures by Type
7.3 Europe Interleukin Inhibitors Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Interleukin Inhibitors by Region
8.1.1 Asia Pacific Interleukin Inhibitors Sales by Region
8.1.2 Asia Pacific Interleukin Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Interleukin Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Interleukin Inhibitors Market Facts & Figures by Application
9 Latin America
9.1 Latin America Interleukin Inhibitors by Country
9.1.1 Latin America Interleukin Inhibitors Sales by Country
9.1.2 Latin America Interleukin Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Interleukin Inhibitors Market Facts & Figures by Type
9.3 Central & South America Interleukin Inhibitors Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Interleukin Inhibitors by Country
10.1.1 Middle East and Africa Interleukin Inhibitors Sales by Country
10.1.2 Middle East and Africa Interleukin Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Interleukin Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Interleukin Inhibitors Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Interleukin Inhibitors Products Offered
11.1.5 Sanofi Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Interleukin Inhibitors Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Interleukin Inhibitors Products Offered
11.3.5 Novartis Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Interleukin Inhibitors Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Description and Business Overview
11.5.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Roche Interleukin Inhibitors Products Offered
11.5.5 Roche Related Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Description and Business Overview
11.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly Interleukin Inhibitors Products Offered
11.6.5 Eli Lilly Related Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Description and Business Overview
11.7.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AstraZeneca Interleukin Inhibitors Products Offered
11.7.5 AstraZeneca Related Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Description and Business Overview
11.8.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teva Pharmaceutical Interleukin Inhibitors Products Offered
11.8.5 Teva Pharmaceutical Related Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Corporation Information
11.9.2 Regeneron Pharmaceuticals Description and Business Overview
11.9.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Regeneron Pharmaceuticals Interleukin Inhibitors Products Offered
11.9.5 Regeneron Pharmaceuticals Related Developments
11.10 Bausch Health
11.10.1 Bausch Health Corporation Information
11.10.2 Bausch Health Description and Business Overview
11.10.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bausch Health Interleukin Inhibitors Products Offered
11.10.5 Bausch Health Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Interleukin Inhibitors Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Interleukin Inhibitors Market Estimates and Projections by Region
12.1.1 Global Interleukin Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Interleukin Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Interleukin Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Interleukin Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Interleukin Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Interleukin Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Interleukin Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Interleukin Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Interleukin Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Interleukin Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Interleukin Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Interleukin Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Interleukin Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Interleukin Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Interleukin Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Interleukin Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Interleukin Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Interleukin Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Interleukin Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Interleukin Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Interleukin Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Interleukin Inhibitors Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Interleukin Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interleukin Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Interleukin Inhibitors Market Segments
Table 2. Ranking of Global Top Interleukin Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Interleukin Inhibitors Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Interleukin 1
Table 5. Major Manufacturers of Interleukin 2
Table 6. Major Manufacturers of Interleukin 3
Table 7. Major Manufacturers of Interleukin 4
Table 8. Major Manufacturers of Others
Table 9. Global Interleukin Inhibitors Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Interleukin Inhibitors Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Interleukin Inhibitors Sales by Regions 2015-2020 (K MT)
Table 12. Global Interleukin Inhibitors Sales Market Share by Regions (2015-2020)
Table 13. Global Interleukin Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Interleukin Inhibitors Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Interleukin Inhibitors Sales Share by Manufacturers (2015-2020)
Table 16. Global Interleukin Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Interleukin Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interleukin Inhibitors as of 2019)
Table 18. Interleukin Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Interleukin Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Interleukin Inhibitors Price (2015-2020) (USD/MT)
Table 21. Interleukin Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Interleukin Inhibitors Product Type
Table 23. Date of International Manufacturers Enter into Interleukin Inhibitors Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Interleukin Inhibitors Sales by Type (2015-2020) (K MT)
Table 26. Global Interleukin Inhibitors Sales Share by Type (2015-2020)
Table 27. Global Interleukin Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Interleukin Inhibitors Revenue Share by Type (2015-2020)
Table 29. Interleukin Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Interleukin Inhibitors Sales by Application (2015-2020) (K MT)
Table 31. Global Interleukin Inhibitors Sales Share by Application (2015-2020)
Table 32. North America Interleukin Inhibitors Sales by Country (2015-2020) (K MT)
Table 33. North America Interleukin Inhibitors Sales Market Share by Country (2015-2020)
Table 34. North America Interleukin Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Interleukin Inhibitors Revenue Market Share by Country (2015-2020)
Table 36. North America Interleukin Inhibitors Sales by Type (2015-2020) (K MT)
Table 37. North America Interleukin Inhibitors Sales Market Share by Type (2015-2020)
Table 38. North America Interleukin Inhibitors Sales by Application (2015-2020) (K MT)
Table 39. North America Interleukin Inhibitors Sales Market Share by Application (2015-2020)
Table 40. Europe Interleukin Inhibitors Sales by Country (2015-2020) (K MT)
Table 41. Europe Interleukin Inhibitors Sales Market Share by Country (2015-2020)
Table 42. Europe Interleukin Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Interleukin Inhibitors Revenue Market Share by Country (2015-2020)
Table 44. Europe Interleukin Inhibitors Sales by Type (2015-2020) (K MT)
Table 45. Europe Interleukin Inhibitors Sales Market Share by Type (2015-2020)
Table 46. Europe Interleukin Inhibitors Sales by Application (2015-2020) (K MT)
Table 47. Europe Interleukin Inhibitors Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Interleukin Inhibitors Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Interleukin Inhibitors Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Interleukin Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Interleukin Inhibitors Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Interleukin Inhibitors Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Interleukin Inhibitors Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Interleukin Inhibitors Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Interleukin Inhibitors Sales Market Share by Application (2015-2020)
Table 56. Latin America Interleukin Inhibitors Sales by Country (2015-2020) (K MT)
Table 57. Latin America Interleukin Inhibitors Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Interleukin Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Interleukin Inhibitors Revenue Market Share by Country (2015-2020)
Table 60. Latin America Interleukin Inhibitors Sales by Type (2015-2020) (K MT)
Table 61. Latin America Interleukin Inhibitors Sales Market Share by Type (2015-2020)
Table 62. Latin America Interleukin Inhibitors Sales by Application (2015-2020) (K MT)
Table 63. Latin America Interleukin Inhibitors Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Interleukin Inhibitors Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Interleukin Inhibitors Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Interleukin Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Interleukin Inhibitors Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Interleukin Inhibitors Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Interleukin Inhibitors Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Interleukin Inhibitors Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Interleukin Inhibitors Sales Market Share by Application (2015-2020)
Table 72. Sanofi Corporation Information
Table 73. Sanofi Description and Major Businesses
Table 74. Sanofi Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Sanofi Product
Table 76. Sanofi Recent Development
Table 77. GlaxoSmithKline Corporation Information
Table 78. GlaxoSmithKline Description and Major Businesses
Table 79. GlaxoSmithKline Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Recent Development
Table 82. Novartis Corporation Information
Table 83. Novartis Description and Major Businesses
Table 84. Novartis Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Novartis Product
Table 86. Novartis Recent Development
Table 87. Johnson & Johnson Corporation Information
Table 88. Johnson & Johnson Description and Major Businesses
Table 89. Johnson & Johnson Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Johnson & Johnson Product
Table 91. Johnson & Johnson Recent Development
Table 92. Roche Corporation Information
Table 93. Roche Description and Major Businesses
Table 94. Roche Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Roche Product
Table 96. Roche Recent Development
Table 97. Eli Lilly Corporation Information
Table 98. Eli Lilly Description and Major Businesses
Table 99. Eli Lilly Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Eli Lilly Product
Table 101. Eli Lilly Recent Development
Table 102. AstraZeneca Corporation Information
Table 103. AstraZeneca Description and Major Businesses
Table 104. AstraZeneca Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. AstraZeneca Product
Table 106. AstraZeneca Recent Development
Table 107. Teva Pharmaceutical Corporation Information
Table 108. Teva Pharmaceutical Description and Major Businesses
Table 109. Teva Pharmaceutical Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Teva Pharmaceutical Product
Table 111. Teva Pharmaceutical Recent Development
Table 112. Regeneron Pharmaceuticals Corporation Information
Table 113. Regeneron Pharmaceuticals Description and Major Businesses
Table 114. Regeneron Pharmaceuticals Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Regeneron Pharmaceuticals Product
Table 116. Regeneron Pharmaceuticals Recent Development
Table 117. Bausch Health Corporation Information
Table 118. Bausch Health Description and Major Businesses
Table 119. Bausch Health Interleukin Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Bausch Health Product
Table 121. Bausch Health Recent Development
Table 122. Global Interleukin Inhibitors Sales Forecast by Regions (2021-2026) (K MT)
Table 123. Global Interleukin Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Interleukin Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Interleukin Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Interleukin Inhibitors Sales Forecast by Country (2021-2026) (K MT)
Table 127. North America: Interleukin Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Interleukin Inhibitors Sales Forecast by Country (2021-2026) (K MT)
Table 129. Europe: Interleukin Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Interleukin Inhibitors Sales Forecast by Region (2021-2026) (K MT)
Table 131. Asia Pacific: Interleukin Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Interleukin Inhibitors Sales Forecast by Country (2021-2026) (K MT)
Table 133. Latin America: Interleukin Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Interleukin Inhibitors Sales Forecast by Country (2021-2026) (K MT)
Table 135. Middle East and Africa: Interleukin Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Interleukin Inhibitors Players
Table 140. Interleukin Inhibitors Customers List
Table 141. Interleukin Inhibitors Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Interleukin Inhibitors Product Picture
Figure 2. Global Interleukin Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Interleukin 1 Product Picture
Figure 4. Interleukin 2 Product Picture
Figure 5. Interleukin 3 Product Picture
Figure 6. Interleukin 4 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Interleukin Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Interleukin Inhibitors Report Years Considered
Figure 13. Global Interleukin Inhibitors Market Size 2015-2026 (US$ Million)
Figure 14. Global Interleukin Inhibitors Sales 2015-2026 (K MT)
Figure 15. Global Interleukin Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Interleukin Inhibitors Sales Market Share by Region (2015-2020)
Figure 17. Global Interleukin Inhibitors Sales Market Share by Region in 2019
Figure 18. Global Interleukin Inhibitors Revenue Market Share by Region (2015-2020)
Figure 19. Global Interleukin Inhibitors Revenue Market Share by Region in 2019
Figure 20. Global Interleukin Inhibitors Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Interleukin Inhibitors Revenue in 2019
Figure 22. Interleukin Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Interleukin Inhibitors Sales Market Share by Type (2015-2020)
Figure 24. Global Interleukin Inhibitors Sales Market Share by Type in 2019
Figure 25. Global Interleukin Inhibitors Revenue Market Share by Type (2015-2020)
Figure 26. Global Interleukin Inhibitors Revenue Market Share by Type in 2019
Figure 27. Global Interleukin Inhibitors Market Share by Price Range (2015-2020)
Figure 28. Global Interleukin Inhibitors Sales Market Share by Application (2015-2020)
Figure 29. Global Interleukin Inhibitors Sales Market Share by Application in 2019
Figure 30. Global Interleukin Inhibitors Revenue Market Share by Application (2015-2020)
Figure 31. Global Interleukin Inhibitors Revenue Market Share by Application in 2019
Figure 32. North America Interleukin Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Interleukin Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Interleukin Inhibitors Sales Market Share by Country in 2019
Figure 35. North America Interleukin Inhibitors Revenue Market Share by Country in 2019
Figure 36. U.S. Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Interleukin Inhibitors Market Share by Type in 2019
Figure 41. North America Interleukin Inhibitors Market Share by Application in 2019
Figure 42. Europe Interleukin Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Interleukin Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Interleukin Inhibitors Sales Market Share by Country in 2019
Figure 45. Europe Interleukin Inhibitors Revenue Market Share by Country in 2019
Figure 46. Germany Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Interleukin Inhibitors Market Share by Type in 2019
Figure 57. Europe Interleukin Inhibitors Market Share by Application in 2019
Figure 58. Asia Pacific Interleukin Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Interleukin Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Interleukin Inhibitors Sales Market Share by Region in 2019
Figure 61. Asia Pacific Interleukin Inhibitors Revenue Market Share by Region in 2019
Figure 62. China Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Interleukin Inhibitors Market Share by Type in 2019
Figure 85. Asia Pacific Interleukin Inhibitors Market Share by Application in 2019
Figure 86. Latin America Interleukin Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Interleukin Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Interleukin Inhibitors Sales Market Share by Country in 2019
Figure 89. Latin America Interleukin Inhibitors Revenue Market Share by Country in 2019
Figure 90. Mexico Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Interleukin Inhibitors Market Share by Type in 2019
Figure 97. Latin America Interleukin Inhibitors Market Share by Application in 2019
Figure 98. Middle East and Africa Interleukin Inhibitors Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Interleukin Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Interleukin Inhibitors Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Interleukin Inhibitors Revenue Market Share by Country in 2019
Figure 102. Turkey Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Interleukin Inhibitors Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Interleukin Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Interleukin Inhibitors Market Share by Type in 2019
Figure 109. Middle East and Africa Interleukin Inhibitors Market Share by Application in 2019
Figure 110. North America Interleukin Inhibitors Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Interleukin Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Interleukin Inhibitors Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Interleukin Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Interleukin Inhibitors Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Interleukin Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Interleukin Inhibitors Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Interleukin Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Interleukin Inhibitors Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Interleukin Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
インターロイキン1アルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Alpha Market The global Interleukin 1 Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Alpha Scope and Market Size Interleukin 1 Alpha market is seg…- インターロイキン12受容体の世界市場（～2026年） Market Analysis and Insights: Global Interleukin 12 Receptor Market The global Interleukin 12 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 12 Receptor Scope and Market Size Interleukin 12 Recept…
- インターロイキン7受容体サブユニットアルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 7 Receptor Subunit Alpha Market The global Interleukin 7 Receptor Subunit Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 7 Receptor Subunit Alpha Scop…
- インターロイキン1受容体関連キナーゼ4の世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Receptor Associated Kinase 4 Market The global Interleukin 1 Receptor Associated Kinase 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Receptor Associ…
- インターロイキン1（IL1）の世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 (IL1) Market The global Interleukin 1 (IL1) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 (IL1) Scope and Market Size Interleukin 1 (IL1) market is seg…